Sign Up for Vincent AI
Takeda Canada Inc. v. Apotex Inc.,
2 cases
Boehringer Ingelheim (Canada) Ltd. v. Jamp Pharma Corporation,
"...Construction A. Legal Principles [58] I recently summarized the principles of claims construction in Takeda Canada Inc v Apotex Inc, 2024 FC 106 at paragraphs 69-74 [Takeda]. These principles, which are equally applicable here, are repeated as follows. [59] The first task for the Court in a..."
Alexion Pharma v. Amgen Canada,
"...the invention. [45] It is the person, or team of individuals, that would work the patent in a real sense: Takeda Canada Inc v Apotex Inc, 2024 FC 106 [Takeda] at para 76; Alcon Canada Inc v Cobalt Pharmaceuticals Company, 2014 FC 462 at para 37, aff’d 2015 FCA 191, 2015 FCA [46] Where the P..."
Try vLex and Vincent AI for free
Start a free trial3 firm's commentaries
DEXILANT Formulation Patent Invalid And Not Infringed By Apotex
"...and failure to disclose the factual basis and line of reasoning for sound prediction of utility: Takeda Canada Inc v Apotex Inc, 2024 FC 106. Background DEXILANT is a "pulsatile release formulation ... that includes two types of delayed-release beads containing dexlansoprazole", and release..."
Dexlansoprazole Formulation Patent Invalid And Not Infringed By Apotex
"...and failure to disclose the factual basis and line of reasoning for sound prediction of utility: Takeda Canada Inc v Apotex Inc, 2024 FC 106. Background DEXILANT is a "pulsatile release formulation ... that includes two types of delayed-release beads containing dexlansoprazole", and release..."
Avoiding The Hindsight Trap In The Context Of A Patent Obviousness Analysis
"...J.) 4. Molo Design Ltd v Chanel Canada ULC, 2024 FC 1260 at para 300 (McHaffie J.) 5. See most recently Takeda Canada Inc v Apotex Inc, 2024 FC 106 at para 198 (Furlanetto 6. Astrazeneca Canada Inc v Apotex Inc, 2015 FC 322 at para 231 (Barnes J.) see also Swist v Meg Energy Corp, 2021 FC 1..."
Try vLex and Vincent AI for free
Start a free trialExperience vLex's unparalleled legal AI
Access millions of documents and let Vincent AI power your research, drafting, and document analysis — all in one platform.
Start Your 3-day Free Trial of vLex and Vincent AI, Your Precision-Engineered Legal Assistant
-
Access comprehensive legal content with no limitations across vLex's unparalleled global legal database
-
Build stronger arguments with verified citations and CERT citator that tracks case history and precedential strength
-
Transform your legal research from hours to minutes with Vincent AI's intelligent search and analysis capabilities
-
Elevate your practice by focusing your expertise where it matters most while Vincent handles the heavy lifting
Start Your 3-day Free Trial of vLex and Vincent AI, Your Precision-Engineered Legal Assistant
-
Access comprehensive legal content with no limitations across vLex's unparalleled global legal database
-
Build stronger arguments with verified citations and CERT citator that tracks case history and precedential strength
-
Transform your legal research from hours to minutes with Vincent AI's intelligent search and analysis capabilities
-
Elevate your practice by focusing your expertise where it matters most while Vincent handles the heavy lifting
2 cases
Boehringer Ingelheim (Canada) Ltd. v. Jamp Pharma Corporation,
"...Construction A. Legal Principles [58] I recently summarized the principles of claims construction in Takeda Canada Inc v Apotex Inc, 2024 FC 106 at paragraphs 69-74 [Takeda]. These principles, which are equally applicable here, are repeated as follows. [59] The first task for the Court in a..."
Alexion Pharma v. Amgen Canada,
"...the invention. [45] It is the person, or team of individuals, that would work the patent in a real sense: Takeda Canada Inc v Apotex Inc, 2024 FC 106 [Takeda] at para 76; Alcon Canada Inc v Cobalt Pharmaceuticals Company, 2014 FC 462 at para 37, aff’d 2015 FCA 191, 2015 FCA [46] Where the P..."
Try vLex and Vincent AI for free
Start a free trialStart Your 3-day Free Trial of vLex and Vincent AI, Your Precision-Engineered Legal Assistant
-
Access comprehensive legal content with no limitations across vLex's unparalleled global legal database
-
Build stronger arguments with verified citations and CERT citator that tracks case history and precedential strength
-
Transform your legal research from hours to minutes with Vincent AI's intelligent search and analysis capabilities
-
Elevate your practice by focusing your expertise where it matters most while Vincent handles the heavy lifting
Start Your 3-day Free Trial of vLex and Vincent AI, Your Precision-Engineered Legal Assistant
-
Access comprehensive legal content with no limitations across vLex's unparalleled global legal database
-
Build stronger arguments with verified citations and CERT citator that tracks case history and precedential strength
-
Transform your legal research from hours to minutes with Vincent AI's intelligent search and analysis capabilities
-
Elevate your practice by focusing your expertise where it matters most while Vincent handles the heavy lifting
3 firm's commentaries
DEXILANT Formulation Patent Invalid And Not Infringed By Apotex
"...and failure to disclose the factual basis and line of reasoning for sound prediction of utility: Takeda Canada Inc v Apotex Inc, 2024 FC 106. Background DEXILANT is a "pulsatile release formulation ... that includes two types of delayed-release beads containing dexlansoprazole", and release..."
Dexlansoprazole Formulation Patent Invalid And Not Infringed By Apotex
"...and failure to disclose the factual basis and line of reasoning for sound prediction of utility: Takeda Canada Inc v Apotex Inc, 2024 FC 106. Background DEXILANT is a "pulsatile release formulation ... that includes two types of delayed-release beads containing dexlansoprazole", and release..."
Avoiding The Hindsight Trap In The Context Of A Patent Obviousness Analysis
"...J.) 4. Molo Design Ltd v Chanel Canada ULC, 2024 FC 1260 at para 300 (McHaffie J.) 5. See most recently Takeda Canada Inc v Apotex Inc, 2024 FC 106 at para 198 (Furlanetto 6. Astrazeneca Canada Inc v Apotex Inc, 2015 FC 322 at para 231 (Barnes J.) see also Swist v Meg Energy Corp, 2021 FC 1..."